APA

Clar H., Renner W., Krippl P., Leithner A., Gruber G., Langsenlehner T., Hofmann G., Yazdani-Biuki B., Clar V., Windhager R. & Langsenlehner U. (20090204). The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer. : Breast cancer research and treatment.

Chicago

Clar H, Renner W, Krippl P, Leithner A, Gruber G, Langsenlehner T, Hofmann G, Yazdani-Biuki B, Clar V, Windhager R and Langsenlehner U. 20090204. The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer. : Breast cancer research and treatment.

Harvard

Clar H., Renner W., Krippl P., Leithner A., Gruber G., Langsenlehner T., Hofmann G., Yazdani-Biuki B., Clar V., Windhager R. and Langsenlehner U. (20090204). The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer. : Breast cancer research and treatment.

MLA

Clar H, Renner W, Krippl P, Leithner A, Gruber G, Langsenlehner T, Hofmann G, Yazdani-Biuki B, Clar V, Windhager R and Langsenlehner U. The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer. : Breast cancer research and treatment. 20090204.